Meetings/Workshops on Hematology in Germany

Fraunhofer Institute for Cell Therapy and Immunology IZI and the University Cancer Center of the University Hospital Leipzig

The Leipzig Immune ONcology (LION) Conference will bring together clinicians, scientists and industry to discuss latest developments and highlights on special issues of immune oncology. This year’s conference will focus on tumor microenvironment, cell-based therapy in hematology and oncology, immune checkpoint inhibitors, biomarkers, cell therapies and cancer vaccines.

The Leipzig Immune ONcology (LION) Conference will be hosted as virtual conference and not as face-to-face event in Leipzig, Germany. In light of the still on-going developments with COVID-19 we've decided to change the conference format for this year.

Fraunhofer Institute for Cell Therapy and Immunology;     Phone: [+49 341 35536-9320];     Email: info@lion-conference.com

oncology, immunology, hematology, biomarkers, immunotherapy, cell therapies, cancer vaccines

Oncology,    Immunology and Allergic Diseases

AEK - Abteilung Experimentelle Krebsforschung

You will see that there is already a rapidly growing line-up of excellent speakers, who will cover multiple exciting topics of current biology, from basic mechanism to new immunotherapies and the development of new molecules. We will select a significant number of talks from the abstracts and provide students, postdocs and junior faculty the chance to present their latest research. In addition, the best posters will be presented as “Flash Talks”. So plan to present your best story at the AEK! We particularly encourage students and postdocs to attend the conference and offer special registration rates for them. In addition, there will be travel bursaries for young investigators.

Kongress- und Kulturmanagement GmbH;     Phone: [+4936432468126];     Email: annett.loss@kukm.de

Cancer Immunology and Immunotherapy, Transcription-driven Tumors and Transcription Stress, Ubiquitin System in Cancer, Cellular Senescence in Cancer, Tumor Microenvironment, Metastasis, Emerging Concepts and Novel Molecules

Deutsche Krebsgesellschaft e. V. (www.krebsgesellschaft.de) und Stiftung Deutsche Krebshilfe (www.krebshilfe.de)

Erfolge in der Krebstherapie hängen auch von der Qualität der einzelnen Schnittstellen ab. Ein schneller Transfer – gesicherter medizinischer Innovationen von Forschung in die Versorgung - ist eine wichtige Voraussetzung für den onkologischen Fortschritt. Die Schnittstelle und Zusammenarbeit aus verschiedenen ärztlichen Fächern und Gesundheitsberufen sowie Patient*innen ist ebenfalls sehr bedeutsam.

Deutsche Krebsgesellschaft e. V. - Frau Janina Henne;     Phone: [+49 30 3229329-21];     Email: dkk2022@krebsgesellschaft.de

Tumormedizin, Krebsforschung, Krebserkrankungen, Tumorarten, Hilfe/Selbsthilfe, Psychoonkologie, Palliativmedizin, Kommunikation, Gesundheitspolitik

Oncology,    Medicine (in general), Internal medicine